CAR-T gene therapy for leukemia clears FDA hurdle – WSAW
WSAW |
CAR-T gene therapy for leukemia clears FDA hurdle
WSAW After decades of setbacks and disappointments in efforts to fix, replace, or change genes to cure diseases, several companies are near the finish line in a race to bring CAR-T and other types of gene therapy to patients. Kite Pharma also has a CAR-T … |
